Subodh S. Deshmukh
Corporate Officer/Principal bei ZYMERGEN INC.
Profil
Subodh S.
Deshmukh is currently the Chief Development Officer at Zymergen, Inc. Prior to this, he worked as the Global Head-Product Development at Novartis, Inc. and Sandoz International GmbH.
He holds a doctorate from the University of Pittsburgh and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Subodh S. Deshmukh
| Unternehmen | Position | Beginn |
|---|---|---|
| ZYMERGEN INC. | Corporate Officer/Principal | 05.08.2021 |
Ehemalige bekannte Positionen von Subodh S. Deshmukh
| Unternehmen | Position | Ende |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | - |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Corporate Officer/Principal | - |
Ausbildung von Subodh S. Deshmukh
| University of Pittsburgh | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Health Technology |
Zymergen, Inc.
 Zymergen, Inc. Miscellaneous Commercial ServicesCommercial Services Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. Its products include electronic films, repellent products, and agriculture products such as traditional synthetic nitrogen fertilizers and traditional chemical-based crop protection products. The company was founded by Zachariah Serber, Jed Dean and Joshua J. Hoffman in 2013 and is headquartered in Emeryville, CA. | Commercial Services |
